Profil

NEYSES Ludwig

University of Luxembourg > CRC > Vice-rectorate for Research

Main Referenced Co-authors
Cartwright, Elizabeth J. (35)
Oceandy, Delvac (31)
Vetter, H. (22)
Mamas, Mamas A. (19)
Mohamed, Tamer M. A. (14)
Main Referenced Keywords
Humans (108); Animals (78); Male (51); Rats (47); Female (46);
Main Referenced Unit & Research Centers
Institute of Cardiovascular Sciences, University of Manchester, Manchester Academic Health Sciences Centre, Manchester M13 9PT, UK (1)
Main Referenced Disciplines
Cardiovascular & respiratory systems (173)
Human health sciences: Multidisciplinary, general & others (14)
Life sciences: Multidisciplinary, general & others (4)
Reproductive medicine (gynecology, andrology, obstetrics) (3)
General & internal medicine (2)

Publications (total 200)

The most downloaded
5100 downloads
Hamm, C. W., Bassand, J.-P., Agewall, S., Bax, J., Boersma, E., Bueno, H., Caso, P., Dudek, D., Gielen, S., Huber, K., Ohman, M., Petrie, M. C., Sonntag, F., Uva, M. S., Storey, R. F., Wijns, W., Zahger, D., & Neyses, L. (Other coll.). (2011). ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal, 32 (23), 2999-3054. doi:10.1093/eurheartj/ehr236 https://hdl.handle.net/10993/27827

The most cited

4680 citations (Scopus®)

McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., Zile, M. R., & Neyses, L. (Other coll.). (2014). Angiotensin-neprilysin inhibition versus enalapril in heart failure. The New England journal of medicine, 371 (11), 993-1004. doi:10.1056/NEJMoa1409077 https://hdl.handle.net/10993/27659

Ozkan, J., & Neyses, L. (01 October 2017). A physician who has crossed many frontiers and has changed direction a number of times . European Heart Journal, 38 (37), 2799–2800.

Kurusamy, S., López-Maderuelo, D., Little, R., Cadagan, D., Savage, A. M., Ihugba, J. C., Baggott, R. R., Rowther, F. B., Martínez-Martínez, S., Gómez-del Arco, P., Murcott, C., Wang, W., Nistal, J. F., Oceandy, D., Neyses, L., Wilkinson, R. N., Cartwright, E. J., Redondo, J. M., & Armesilla, A. L. (2017). Selective inhibition of plasma membrane calcium ATPase 4 improves angiogenesis and vascular reperfusion. Journal of Molecular and Cellular Cardiology, (109), 38-47. doi:10.1016/j.yjmcc.2017.07.001
Peer reviewed

Stafford, N., Wilson, C., Oceandy, D., Neyses, L., & Cartwright, E. J. (2017). The Plasma Membrane Calcium ATPases and Their Role as Major New Players in Human Disease. Physiological Reviews, 97 (3), 1089-1125. doi:10.1152/physrev.00028.2016
Peer Reviewed verified by ORBi

Neyses, L., Mohamed, T., Abou-Leisa, R., Stafford, N., Maqsood, A., Zi, M., Prehar, S., Baudoin-Stanley, F., Wang, X., Cartwright, E., & Oceandy, D. (2016). The Plasma Membrane Calcium ATPase 4 Signaling in Cardiac Fibroblasts Mediates Cardiomyocyte Hypertrophy. Nature Communications. doi:10.1038/ncomms11074
Peer Reviewed verified by ORBi

Kristensen, S. L., Preiss, D., Jhund, P. S., Squire, I., Cardoso, J. S., Merkely, B., Martinez, F., Starling, R. C., Desai, A. S., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., Zile, M. R., McMurray, J. J. V., Packer, M., & Neyses, L. (Other coll.). (2016). Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial. Circulation: Heart Failure, 9 (1). doi:10.1161/CIRCHEARTFAILURE.115.002560
Peer Reviewed verified by ORBi

Ritchie, J., Green, D., Chrysochou, T., Hegarty, J., Handley, K., Ives, N., Wheatley, K., Houston, G., Wright, J., Neyses, L., Chalmers, N., Mark, P., Patel, R., Moss, J., Roditi, G., Eadington, D., Lukaschuk, E., Cleland, J., & Kalra, P. A. (2016). Effect of renal artery revascularization upon cardiac structure and function in atherosclerotic renal artery stenosis: cardiac magnetic resonance sub-study of the ASTRAL trial. Nephrology Dialysis Transplantation. doi:10.1093/ndt/gfw107
Peer Reviewed verified by ORBi

Little, R., Cartwright, E. J., Neyses, L., & Austin, C. (2016). Plasma membrane calcium ATPases (PMCAs) as potential targets for the treatment of essential hypertension. Pharmacology and Therapeutics, 159, 23-34. doi:10.1016/j.pharmthera.2016.01.013
Peer Reviewed verified by ORBi

Packer, M., McMurray, J. J. V., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., Zile, M., Andersen, K., Arango, J. L., Arnold, J. M., Belohlavek, J., Bohm, M., Boytsov, S., Burgess, L. J., Cabrera, W., ... Neyses, L. (Other coll.). (2015). Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure. Circulation, 131 (1), 54-61. doi:10.1161/CIRCULATIONAHA.114.013748
Peer Reviewed verified by ORBi

Ryan, Z. C., Craig, T. A., Filoteo, A. G., Westendorf, J. J., Cartwright, E. J., Neyses, L., Strehler, E. E., & Kumar, R. (2015). Deletion of the intestinal plasma membrane calcium pump, isoform 1, Atp2b1, in mice is associated with decreased bone mineral density and impaired responsiveness to 1, 25-dihydroxyvitamin D3. Biochemical and Biophysical Research Communications, 467 (1), 152-6. doi:10.1016/j.bbrc.2015.09.087
Peer reviewed

Baggott, R. R., Alfranca, A., Lopez-Maderuelo, D., Mohamed, T. M. A., Escolano, A., Oller, J., Ornes, B. C., Kurusamy, S., Rowther, F. B., Brown, J. E., Oceandy, D., Cartwright, E. J., Wang, W., Gomez-del Arco, P., Martinez-Martinez, S., Neyses, L., Redondo, J. M., & Armesilla, A. L. (2014). Plasma membrane calcium ATPase isoform 4 inhibits vascular endothelial growth factor-mediated angiogenesis through interaction with calcineurin. Arteriosclerosis, Thrombosis and Vascular Biology, 34 (10), 2310-20. doi:10.1161/ATVBAHA.114.304363
Peer Reviewed verified by ORBi

McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., Zile, M. R., & Neyses, L. (Other coll.). (2014). Angiotensin-neprilysin inhibition versus enalapril in heart failure. The New England journal of medicine, 371 (11), 993-1004. doi:10.1056/NEJMoa1409077
Peer reviewed

Fath-Ordoubadi, F. A., Spaepen, E. B., El-Omar, M. A., Fraser, D. G. A., Khan, M. A. A., Neyses, L., Danzi, G. B. C., Roguin, A. D., Paunovic, D. E., & Mamas, M. A. A. F. (2014). Outcomes in patients with acute and stable coronary syndromes; insights from the prospective NOBORI-2 study. PLoS ONE, 9 (2). doi:10.1371/journal.pone.0088577
Peer Reviewed verified by ORBi

Mohamed, T. M. A., Zi, M., Prehar, S., Maqsood, A., Abou-Leisa, R., Nguyen, L., Pfeifer, G. P., Cartwright, E. J., Neyses, L., & Oceandy, D. (2014). The tumour suppressor Ras-association domain family protein 1A (RASSF1A) regulates TNF-alpha signalling in cardiomyocytes. Cardiovascular Research, 103 (1), 47-59. doi:10.1093/cvr/cvu111
Peer Reviewed verified by ORBi

Zi, M., Maqsood, A., Prehar, S., Mohamed, T. M. A., Abou-Leisa, R., Robertson, A., Cartwright, E. J., Ray, S. G., Oh, S., Lim, D.-S., Neyses, L., & Oceandy, D. (2014). The mammalian Ste20-like kinase 2 (Mst2) modulates stress-induced cardiac hypertrophy. The Journal of biological chemistry, 289 (35), 24275-88. doi:10.1074/jbc.M114.562405
Peer reviewed

Mamas, M. A., Anderson, S. G., Ratib, K., Routledge, H., Neyses, L., Fraser, D. G., Buchan, I., de Belder, M. A., Ludman, P., & Nolan, J. (2014). Arterial access site utilization in cardiogenic shock in the United Kingdom: is radial access feasible? American Heart Journal, 167 (6), 900-8.e1. doi:10.1016/j.ahj.2014.03.007
Peer Reviewed verified by ORBi

Ryden, L., Grant, P. J., Anker, S. D., Berne, C., Cosentino, F., Danchin, N., Deaton, C., Escaned, J., Hammes, H.-P., Huikuri, H., Marre, M., Marx, N., Mellbin, L., Ostergren, J., Patrono, C., Seferovic, P., Uva, M. S., Taskinen, M.-R., Tendera, M., ... Neyses, L. (Other coll.). (2014). ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - summary. Diabetes and Vascular Disease Research, 11 (3), 133-73. doi:10.1177/1479164114525548
Peer Reviewed verified by ORBi

Mamas, M. A., Fraser, D. G., Ratib, K., Fath-Ordoubadi, F., El-Omar, M., Nolan, J., & Neyses, L. (2014). Minimising radial injury: Prevention is better than cure. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 10 (7), 824-832. doi:10.4244/EIJV10I7A142
Peer reviewed

Khan, M. A., Deaton, C., Rutter, M. K., Neyses, L., & Mamas, M. A. (March 2013). Incretins as a novel therapeutic strategy in patients with diabetes and heart failure. Heart Failure Reviews, 18 (2), 141-8. doi:10.1007/s10741-012-9318-y
Peer Reviewed verified by ORBi

Egom, E. E., Rose, R. A., Neyses, L., Soran, H., Cleland, J. G. F., & Mamas, M. A. (2013). Activation of sphingosine-1-phosphate signalling as a potential underlying mechanism of the pleiotropic effects of statin therapy. Critical Reviews in Clinical Laboratory Sciences, 50 (3), 79-89. doi:10.3109/10408363.2013.813013
Peer Reviewed verified by ORBi

Khan, M. A., Ahmed, F., Neyses, L., & Mamas, M. A. (2013). Atrial fibrillation in heart failure: The sword of Damocles revisited. World Journal of Cardiology, 5 (7), 215-27. doi:10.4330/wjc.v5.i7.215
Peer Reviewed verified by ORBi

Egom, E. E., Mamas, M. A., Chacko, S., Stringer, S. E., Charlton-Menys, V., El-Omar, M., Chirico, D., Clarke, B., Neyses, L., Cruickshank, J. K., Lei, M., & Fath-Ordoubadi, F. (2013). Serum sphingolipids level as a novel potential marker for early detection of human myocardial ischaemic injury. Frontiers in Physiology, 4, 130. doi:10.3389/fphys.2013.00130
Peer Reviewed verified by ORBi

Ryden, L., Grant, P. J., Anker, S. D., Berne, C., Cosentino, F., Danchin, N., Deaton, C., Escaned, J., Hammes, H.-P., Huikuri, H., Marre, M., Marx, N., Mellbin, L., Ostergren, J., Patrono, C., Seferovic, P., Uva, M. S., Taskinen, M.-R., Tendera, M., ... Xuereb, R. G. (2013). ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). European Heart Journal, 34 (39), 3035-87. doi:10.1093/eurheartj/eht108
Peer Reviewed verified by ORBi

Fiuzat, M., O'Connor, C. M., Gueyffier, F., Mascette, A. M., Geller, N. L., Mebazaa, A., Voors, A. A., Adams, K. F., Pina, I. L., Neyses, L., Muntendam, P., Felker, G. M., Pitt, B., Zannad, F., & Bristow, M. R. (2013). Biomarker-guided therapies in heart failure: a forum for unified strategies. Journal of Cardiac Failure, 19 (8), 592-9. doi:10.1016/j.cardfail.2013.05.012
Peer Reviewed verified by ORBi

Mohamed, T. M. A., Abou-Leisa, R., Baudoin, F., Stafford, N., Neyses, L., Cartwright, E. J., & Oceandy, D. (2013). Development and characterization of a novel fluorescent indicator protein PMCA4-GCaMP2 in cardiomyocytes. Journal of Molecular and Cellular Cardiology, 63, 57-68. doi:10.1016/j.yjmcc.2013.07.007
Peer Reviewed verified by ORBi

Mamas, M. A., Ratib, K., Routledge, H., Neyses, L., Fraser, D. G., de Belder, M., Ludman, P. F., & Nolan, J. (2013). Influence of arterial access site selection on outcomes in primary percutaneous coronary intervention: are the results of randomized trials achievable in clinical practice? JACC. Cardiovascular Interventions, 6 (7), 698-706. doi:10.1016/j.jcin.2013.03.011
Peer Reviewed verified by ORBi

Liu, W., Zi, M., Tsui, H., Chowdhury, S. K., Zeef, L., Meng, Q.-J., Travis, M., Prehar, S., Berry, A., Hanley, N. A., Neyses, L., Xiao, R.-P., Oceandy, D., Ke, Y., Solaro, R. J., Cartwright, E. J., Lei, M., & Wang, X. (2013). A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostin. Circulation: Heart Failure, 6 (4), 833-44. doi:10.1161/CIRCHEARTFAILURE.112.000123
Peer Reviewed verified by ORBi

Ahmed, F. Z., Khattar, R. S., Zaidi, A. M., Neyses, L., Oceandy, D., & Mamas, M. (2013). Pacing-induced cardiomyopathy: pathophysiological insights through matrix metalloproteinases. Heart Failure Reviews. doi:10.1007/s10741-013-9390-y
Peer Reviewed verified by ORBi

Mohamed, T. M. A., Zakeri, S. A., Baudoin, F., Wolf, M., Oceandy, D., Cartwright, E. J., Gul, S., & Neyses, L. (2013). Optimisation and validation of a high throughput screening compatible assay to identify inhibitors of the plasma membrane calcium ATPase pump--a novel therapeutic target for contraception and malaria. Journal of Pharmacy and Pharmaceutical Sciences, 16 (2), 217-30. doi:10.18433/j3pg68
Peer Reviewed verified by ORBi

Mamas, M. A., Ratib, K., Routledge, H., Fath-Ordoubadi, F., Neyses, L., Louvard, Y., Fraser, D. G., & Nolan, J. (06 December 2012). Influence of access site selection on PCI-related adverse events in patients with STEMI: meta-analysis of randomised controlled trials. Heart, 98 (4), 303-11. doi:10.1136/heartjnl-2011-300558
Peer Reviewed verified by ORBi

Mamas, M. A., Farooq, V., Latib, A., Sastry, S., D'Souza, S., Williams, P., Wiper, A., Neyses, L., El-Omar, M., Fraser, D. G., & Fath-Ordoubadi, F. (2012). Use of the Sideguard (Cappella) stent in bifurcation lesions: a real-world experience. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 7 (10), 1170-80. doi:10.4244/EIJV7I10A188
Peer Reviewed verified by ORBi

Neyses, L. (2012). Cardiac metabolism; from bench to bedside: Diabetic cardiomyopathy, a disease of cardiac metabolism? In J. D. Schilling & D. L. Mann (Eds.), Diabetic cardiomyopathy: bench to bedside. London, United Kingdom: Royal Society of Medicine Press Ltd. doi:10.1016/j.hfc.2012.06.007
Peer reviewed

Mega, J. L., Braunwald, E., Wiviott, S. D., Bassand, J.-P., Bhatt, D. L., Bode, C., Burton, P., Cohen, M., Cook-Bruns, N., Fox, K. A. A., Goto, S., Murphy, S. A., Plotnikov, A. N., Schneider, D., Sun, X., Verheugt, F. W. A., Gibson, C. M., & Neyses, L. (Other coll.). (2012). Rivaroxaban in patients with a recent acute coronary syndrome. The New England journal of medicine, 366 (1), 9-19. doi:10.1056/NEJMoa1112277
Peer reviewed

Prendergast, B., Coope, L. T., Crijns, H., Falkenstein, E., Folsch, U., Halvorsen, S., Janssens, S., Jokinen, E., Kroemer, H. K., Lucke, A., Murer, H., Nagel, E., Neyses, L., Perk, J., Probst-Hensch, N., Rietschel, E. T., Rutten, H., Steingen, C., Tedgui, A., ... Kristensen, S. D. (2012). The German Centre for Cardiovascular Research. European Heart Journal, 33 (9), 1033-36,1036. doi:10.1093/eurheartj/ehs093
Peer Reviewed verified by ORBi

Hegab, Z., Gibbons, S., Neyses, L., & Mamas, M. A. (2012). Role of advanced glycation end products in cardiovascular disease. World Journal of Cardiology, 4 (4), 90-102. doi:10.4330/wjc.v4.i4.90
Peer Reviewed verified by ORBi

Tierney, S., Mamas, M., Woods, S., Rutter, M. K., Gibson, M., Neyses, L., & Deaton, C. (2012). What strategies are effective for exercise adherence in heart failure? A systematic review of controlled studies. Heart Failure Reviews, 17 (1), 107-15. doi:10.1007/s10741-011-9252-4
Peer Reviewed verified by ORBi

Baggott, R. R., Mohamed, T. M. A., Oceandy, D., Holton, M., Blanc, M. C., Roux-Soro, S. C., Brown, S., Brown, J. E., Cartwright, E. J., Wang, W., Neyses, L., & Armesilla, A. L. (2012). Disruption of the interaction between PMCA2 and calcineurin triggers apoptosis and enhances paclitaxel-induced cytotoxicity in breast cancer cells. Carcinogenesis, 33 (12), 2362-8. doi:10.1093/carcin/bgs282
Peer Reviewed verified by ORBi

Khan, M. A., Neyses, L., & Mamas, M. A. (2012). Atrial fibrillation in heart failure: an innocent bystander? Current Cardiology Reviews, 8 (4), 273-80. doi:10.2174/157340312803760839
Peer Reviewed verified by ORBi

Liu, W., Zi, M., Naumann, R., Ulm, S., Jin, J., Taglieri, D. M., Prehar, S., Gui, J., Tsui, H., Xiao, R.-P., Neyses, L., Solaro, R. J., Ke, Y., Cartwright, E. J., Lei, M., & Wang, X. (2011). Pak1 as a novel therapeutic target for antihypertrophic treatment in the heart. Circulation, 124 (24), 2702-15. doi:10.1161/CIRCULATIONAHA.111.048785
Peer Reviewed verified by ORBi

Cartwright, E. J., Oceandy, D., Austin, C., & Neyses, L. (2011). Ca2+ signalling in cardiovascular disease: the role of the plasma membrane calcium pumps. Science China Life Sciences, 54 (8), 691-8. doi:10.1007/s11427-011-4199-1
Peer Reviewed verified by ORBi

Hamm, C. W., Bassand, J.-P., Agewall, S., Bax, J., Boersma, E., Bueno, H., Caso, P., Dudek, D., Gielen, S., Huber, K., Ohman, M., Petrie, M. C., Sonntag, F., Uva, M. S., Storey, R. F., Wijns, W., Zahger, D., & Neyses, L. (Other coll.). (2011). ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal, 32 (23), 2999-3054. doi:10.1093/eurheartj/ehr236
Peer Reviewed verified by ORBi

Appleby, C. E., Khattar, R. S., Morgan, K., Clarke, B., Curzen, N., Neyses, L., & Fath-Ordoubadi, F. (2011). Drug eluting stents for the treatment of bare metal in-stent restenosis: long-term outcomes in real world practice. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 6 (6), 748-53. doi:10.4244/EIJV6I6A127
Peer Reviewed verified by ORBi

Nair, S., Fath-Ordoubadi, F., Clarke, B., El-Omar, M., Foley, J., Fraser, D. G., Mahadevan, V. S., Neyses, L., Khattar, R. S., & Mamas, M. A. (2011). Late outcomes of drug eluting and bare metal stents in saphenous vein graft percutaneous coronary intervention. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 6 (8), 985-91. doi:10.4244/EIJV6I8A170
Peer Reviewed verified by ORBi

Dunn, W. B., Goodacre, R., Neyses, L., & Mamas, M. (2011). Integration of metabolomics in heart disease and diabetes research: current achievements and future outlook. Bioanalysis, 3 (19), 2205-22. doi:10.4155/bio.11.223
Peer Reviewed verified by ORBi

Brown, M., Wedge, D. C., Goodacre, R., Kell, D. B., Baker, P. N., Kenny, L. C., Mamas, M. A., Neyses, L., & Dunn, W. B. (2011). Automated workflows for accurate mass-based putative metabolite identification in LC/MS-derived metabolomic datasets. Bioinformatics, 27 (8), 1108-12. doi:10.1093/bioinformatics/btr079
Peer reviewed

Mamas, M., Dunn, W. B., Neyses, L., & Goodacre, R. (2011). The role of metabolites and metabolomics in clinically applicable biomarkers of disease. Archives of Toxicology, 85 (1), 5-17. doi:10.1007/s00204-010-0609-6
Peer Reviewed verified by ORBi

Mohamed, T. M. A., Oceandy, D., Zi, M., Prehar, S., Alatwi, N., Wang, Y., Shaheen, M. A., Abou-Leisa, R., Schelcher, C., Hegab, Z., Baudoin, F., Emerson, M., Mamas, M., Di Benedetto, G., Zaccolo, M., Lei, M., Cartwright, E. J., & Neyses, L. (2011). Plasma membrane calcium pump (PMCA4)-neuronal nitric-oxide synthase complex regulates cardiac contractility through modulation of a compartmentalized cyclic nucleotide microdomain. The Journal of biological chemistry, 286 (48), 41520-9. doi:10.1074/jbc.M111.290411
Peer reviewed

Cartwright, E. J., Mohamed, T., Oceandy, D., & Neyses, L. (2011). Calcium signaling dysfunction in heart disease. BioFactors (Oxford, England), 37 (3), 175-81. doi:10.1002/biof.149
Peer reviewed

Tierney, S., Elwers, H., Sange, C., Mamas, M., Rutter, M. K., Gibson, M., Neyses, L., & Deaton, C. (2011). What influences physical activity in people with heart failure?: a qualitative study. International Journal of Nursing Studies, 48 (10), 1234-43. doi:10.1016/j.ijnurstu.2011.03.003
Peer Reviewed verified by ORBi

Mamas, M. A., Foley, J., Nair, S., Wiper, A., Clarke, B., El-Omar, M., Fraser, D. G., Khattar, R., Neyses, L., & Fath-Ordoubadi, F. (2011). A comparison of drug-eluting stents versus bare metal stents in saphenous vein graft PCI outcomes: a meta-analysis. Journal of Interventional Cardiology, 24 (2), 172-80. doi:10.1111/j.1540-8183.2010.00620.x
Peer Reviewed verified by ORBi

Zi, M., Kimura, T. E., Liu, W., Jin, J., Higham, J., Kharche, S., Hao, G., Shi, Y., Shen, W., Prehar, S., Mironov, A., Neyses, L., Bierhuizen, M. F. A., Boyett, M. R., Zhang, H., Lei, M., Cartwright, E. J., & Wang, X. (2011). Mitogen-activated protein kinase kinase 4 deficiency in cardiomyocytes causes connexin 43 reduction and couples hypertrophic signals to ventricular arrhythmogenesis. The Journal of biological chemistry, 286 (20), 17821-30. doi:10.1074/jbc.M111.228791
Peer reviewed

Oceandy, D., Mohamed, T. M. A., Cartwright, E. J., & Neyses, L. (2011). Local signals with global impacts and clinical implications: lessons from the plasma membrane calcium pump (PMCA4). Biochimica et biophysica acta, 1813 (5), 974-8. doi:10.1016/j.bbamcr.2010.12.007
Peer reviewed

Cleland, J. G. F., Teerlink, J. R., Senior, R., Nifontov, E. M., Mc Murray, J. J. V., Lang, C. C., Tsyrlin, V. A., Greenberg, B. H., Mayet, J., Francis, D. P., Shaburishvili, T., Monaghan, M., Saltzberg, M., Neyses, L., Wasserman, S. M., Lee, J. H., Saikali, K. G., Clarke, C. P., Goldman, J. H., ... Malik, F. I. (2011). The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial. The Lancet, 378 (9792), 676-83. doi:10.1016/S0140-6736(11)61126-4
Peer Reviewed verified by ORBi

Tierney, S., Mamas, M., Skelton, D., Woods, S., Rutter, M. K., Gibson, M., Neyses, L., & Deaton, C. (2011). What can we learn from patients with heart failure about exercise adherence? A systematic review of qualitative papers. Health Psychology, 30 (4), 401-10. doi:10.1037/a0022848
Peer Reviewed verified by ORBi

Liu, W., Zi, M., Chi, H., Jin, J., Prehar, S., Neyses, L., Cartwright, E. J., Flavell, R. A., Davis, R. J., & Wang, X. (2011). Deprivation of MKK7 in cardiomyocytes provokes heart failure in mice when exposed to pressure overload. Journal of Molecular and Cellular Cardiology, 50 (4), 702-11. doi:10.1016/j.yjmcc.2011.01.013
Peer Reviewed verified by ORBi

Holton, M., Mohamed, T. M. A., Oceandy, D., Wang, W., Lamas, S., Emerson, M., Neyses, L., & Armesilla, A. L. (2010). Endothelial nitric oxide synthase activity is inhibited by the plasma membrane calcium ATPase in human endothelial cells. Cardiovascular Research, 87 (3), 440-8. doi:10.1093/cvr/cvq077
Peer Reviewed verified by ORBi

Holton, M. L., Wang, W., Emerson, M., Neyses, L., & Armesilla, A. L. (2010). Plasma membrane calcium ATPase proteins as novel regulators of signal transduction pathways. World Journal of Biological Chemistry, 1 (6), 201-8. doi:10.4331/wjbc.v1.i6.201
Peer Reviewed verified by ORBi

Mamas, M. A., Horner, S., Welch, E., Ashworth, A., Millington, S., Fraser, D., Fath-Ordoubadi, F., Neyses, L., & El-Omar, M. (2010). Resting Pd/Pa measured with intracoronary pressure wire strongly predicts fractional flow reserve. The Journal of invasive cardiology, 22 (6), 260-5.
Peer reviewed

Kimura, T. E., Jin, J., Zi, M., Prehar, S., Liu, W., Oceandy, D., Abe, J.-I., Neyses, L., Weston, A. H., Cartwright, E. J., & Wang, X. (2010). Targeted deletion of the extracellular signal-regulated protein kinase 5 attenuates hypertrophic response and promotes pressure overload-induced apoptosis in the heart. Circulation Research, 106 (5), 961-70. doi:10.1161/CIRCRESAHA.109.209320
Peer Reviewed verified by ORBi

Mamas, M., D'Souza, S., Hendry, C., Ali, R., Iles-Smith, H., Palmer, K., El-Omar, M., Fath-Ordoubadi, F., Neyses, L., & Fraser, D. G. (2010). Use of the sheathless guide catheter during routine transradial percutaneous coronary intervention: a feasibility study. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 75 (4), 596-602. doi:10.1002/ccd.22246
Peer reviewed

Cartwright, E. J., & Neyses, L. (2010). Evaluation of plasma membrane calcium/calmodulin-dependent ATPase isoform 4 as a potential target for fertility control. Handbook of Experimental Pharmacology, (198), 79-95. doi:10.1007/978-3-642-02062-9_6
Peer Reviewed verified by ORBi

Mamas, M. A., Deaton, C., Rutter, M. K., Yuille, M., Williams, S. G., Ray, S. G., New, J., Gibson, J. M., & Neyses, L. (2010). Impaired glucose tolerance and insulin resistance in heart failure: underrecognized and undertreated? Journal of Cardiac Failure, 16 (9), 761-8. doi:10.1016/j.cardfail.2010.05.027
Peer Reviewed verified by ORBi

Caldwell, J. C., Mamas, M. A., Neyses, L., & Garratt, C. J. (2010). What are the thromboembolic risks of heart failure combined with chronic or paroxysmal AF? Journal of Cardiac Failure, 16 (4), 340-7. doi:10.1016/j.cardfail.2009.12.004
Peer Reviewed verified by ORBi

Gupta, S., Waywell, C., Gandhi, N., Clayton, N., Keevil, B., Clark, A. L., Ng, L. L., Brooks, N., & Neyses, L. (2010). The effects of adding torasemide to standard therapy on peak oxygen consumption, natriuretic peptides, and quality of life in patients with compensated left ventricular systolic dysfunction. European Journal of Heart Failure, 12 (7), 746-52. doi:10.1093/eurjhf/hfq090
Peer Reviewed verified by ORBi

Neyses, L., & Mamas, M. (2010). Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomized controlled trials. Student BMJ, (18).
Peer reviewed

Mamas, M. A., Neyses, L., & Fath-Ordoubadi, F. (2010). A meta-analysis of glucose-insulin-potassium therapy for treatment of acute myocardial infarction. Experimental and Clinical Cardiology, 15 (2), 20-4.
Peer Reviewed verified by ORBi

Jones, S., Solomon, A., Sanz-Rosa, D., Moore, C., Holbrook, L., Cartwright, E. J., Neyses, L., & Emerson, M. (2010). The plasma membrane calcium ATPase modulates calcium homeostasis, intracellular signaling events and function in platelets. Journal of Thrombosis and Haemostasis, 8 (12), 2766-74. doi:10.1111/j.1538-7836.2010.04076.x
Peer Reviewed verified by ORBi

Mohamed, T. M. A., Baudoin-Stanley, F. M., Abou-Leisa, R., Cartwright, E., Neyses, L., & Oceandy, D. (2010). Measurement of plasma membrane calcium-calmodulin-dependent ATPase (PMCA) activity. Methods in Molecular Biology, 637, 333-42. doi:10.1007/978-1-60761-700-6_18
Peer Reviewed verified by ORBi

Mamas, M. A., Eichhofer, J., Hendry, C., El-Omar, M., Clarke, B., Neyses, L., Fath-Ordoubadi, F., & Fraser, D. (2009). Use of the Heartrail II catheter as a distal stent delivery device; an extended case series. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 5 (2), 265-71. doi:10.4244/EIJV5I2A41
Peer Reviewed verified by ORBi

Liu, W., Zi, M., Jin, J., Prehar, S., Oceandy, D., Kimura, T. E., Lei, M., Neyses, L., Weston, A. H., Cartwright, E. J., & Wang, X. (2009). Cardiac-specific deletion of mkk4 reveals its role in pathological hypertrophic remodeling but not in physiological cardiac growth. Circulation Research, 104 (7), 905-14. doi:10.1161/CIRCRESAHA.108.188292
Peer Reviewed verified by ORBi

Oceandy, D., Pickard, A., Prehar, S., Zi, M., Mohamed, T. M. A., Stanley, P. J., Baudoin-Stanley, F., Nadif, R., Tommasi, S., Pfeifer, G. P., Armesilla, A. L., Cartwright, E. J., & Neyses, L. (2009). Tumor suppressor Ras-association domain family 1 isoform A is a novel regulator of cardiac hypertrophy. Circulation, 120 (7), 607-16. doi:10.1161/CIRCULATIONAHA.109.868554
Peer Reviewed verified by ORBi

Oceandy, D., Cartwright, E. J., & Neyses, L. (2009). Ras-association domain family member 1A (RASSF1A)-where the heart and cancer meet. Trends in Cardiovascular Medicine, 19 (8), 262-7. doi:10.1016/j.tcm.2010.02.008
Peer Reviewed verified by ORBi

Mamas, M. A., Caldwell, J. C., Chacko, S., Garratt, C. J., Fath-Ordoubadi, F., & Neyses, L. (2009). A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure. European journal of heart failure, 11 (7), 676-83. doi:10.1093/eurjhf/hfp085
Peer reviewed

Mohamed, T. M. A., Oceandy, D., Prehar, S., Alatwi, N., Hegab, Z., Baudoin, F. M., Pickard, A., Zaki, A. O., Nadif, R., Cartwright, E. J., & Neyses, L. (2009). Specific role of neuronal nitric-oxide synthase when tethered to the plasma membrane calcium pump in regulating the beta-adrenergic signal in the myocardium. The Journal of biological chemistry, 284 (18), 12091-8. doi:10.1074/jbc.M809112200
Peer reviewed

Caldwell, J. C., Contractor, H., Petkar, S., Ali, R., Clarke, B., Garratt, C. J., Neyses, L., & Mamas, M. A. (2009). Atrial fibrillation is under-recognized in chronic heart failure: insights from a heart failure cohort treated with cardiac resynchronization therapy. Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology, 11 (10), 1295-300. doi:10.1093/europace/eup201
Peer Reviewed verified by ORBi

Jazbutyte, V., Kehl, F., Neyses, L., & Pelzer, T. (2009). Estrogen receptor alpha interacts with 17beta-hydroxysteroid dehydrogenase type 10 in mitochondria. Biochemical and Biophysical Research Communications, 384 (4), 450-4. doi:10.1016/j.bbrc.2009.04.139
Peer reviewed

Izzard, A. S., Emerson, M., Prehar, S., Neyses, L., Trainer, P., List, E. O., Kopchick, J. J., & Heagerty, A. M. (2009). The cardiovascular phenotype of a mouse model of acromegaly. Growth Hormone and IGF Research, 19 (5), 413-9. doi:10.1016/j.ghir.2008.12.006
Peer Reviewed verified by ORBi

Cartwright, E. J., Oceandy, D., & Neyses, L. (2009). Physiological implications of the interaction between the plasma membrane calcium pump and nNOS. Pflügers Archiv: European Journal of Physiology, 457 (3), 665-71. doi:10.1007/s00424-008-0455-z
Peer reviewed

Jazbutyte, V., Arias-Loza, P. A., Hu, K., Widder, J., Govindaraj, V., von Poser-Klein, C., Bauersachs, J., Fritzemeier, K.-H., Hegele-Hartung, C., Neyses, L., Ertl, G., & Pelzer, T. (2008). Ligand-dependent activation of ER{beta} lowers blood pressure and attenuates cardiac hypertrophy in ovariectomized spontaneously hypertensive rats. Cardiovascular Research, 77 (4), 774-81. doi:10.1093/cvr/cvm081
Peer Reviewed verified by ORBi

Mamas, M. A., Fraser, D., & Neyses, L. (2008). Cardiovascular manifestations associated with influenza virus infection. International Journal of Cardiology, 130 (3), 304-9. doi:10.1016/j.ijcard.2008.04.044
Peer Reviewed verified by ORBi

Mamas, M. A., Alonso, A., & Neyses, L. (2008). Extensive catheter-induced aortic dissection. The Canadian Journal of Cardiology, 24 (2), 9-10. doi:10.1016/s0828-282x(08)70578-6
Peer Reviewed verified by ORBi

Caldwell, J., Mamas, M., Garratt, C., & Neyses, L. (2008). How common is asymptomatic paroxysmal atrial fibrillation in chronic heart failure? Scandinavian Cardiovascular Journal, 42 (6), 366; author reply 367. doi:10.1080/14017430802492372
Peer Reviewed verified by ORBi

Arias-Loza, P.-A., Hu, K., Dienesch, C., Mehlich, A. M., Konig, S., Jazbutyte, V., Neyses, L., Hegele-Hartung, C., Heinrich Fritzemeier, K., & Pelzer, T. (2007). Both estrogen receptor subtypes, alpha and beta, attenuate cardiovascular remodeling in aldosterone salt-treated rats. Hypertension, 50 (2), 432-8. doi:10.1161/HYPERTENSIONAHA.106.084798
Peer Reviewed verified by ORBi

Oceandy, D., Cartwright, E. J., Emerson, M., Prehar, S., Baudoin, F. M., Zi, M., Alatwi, N., Venetucci, L., Schuh, K., Williams, J. C., Armesilla, A. L., & Neyses, L. (2007). Neuronal nitric oxide synthase signaling in the heart is regulated by the sarcolemmal calcium pump 4b. Circulation, 115 (4), 483-92. doi:10.1161/CIRCULATIONAHA.106.643791
Peer Reviewed verified by ORBi

Neyses, L., & Neyes, L. (2007). A change of scene: Ludwig Neyses, MD. Interview by Mark Nicholls. Circulation, 116 (3), 13-5. doi:10.1161/CIRCULATIONAHA.107.185651

Dunn, W. B. A. B., Deepak, S. M., Buch, M. H., McDowell, G., Spasic, I., Ellis, D. I., Brooks, N., Kell, D. B., & Neyses, L. (2007). Serum metabolomics reveals many novel metabolic markers of heart failure, including pseudouridine and 2-oxoglutarate. Metabolomics, 3 (4), 413-426. doi:10.1007/s11306-007-0063-5
Peer reviewed

Neyses, L., & Buch, M. (2007). Mechanisms of disease: An introduction to clinical sciences. In H. Tomlinson, A. Heagerty, A. Weetman, ... R. Malik (Eds.), Heart Failure (pp. 178-90). United Kingdom: Cambridge University Press.
Peer reviewed

Burkard, N., Rokita, A. G., Kaufmann, S. G., Hallhuber, M., Wu, R., Hu, K., Hofmann, U., Bonz, A., Frantz, S., Cartwright, E. J., Neyses, L., Maier, L. S., Maier, S. K. G., Renne, T., Schuh, K., & Ritter, O. (2007). Conditional neuronal nitric oxide synthase overexpression impairs myocardial contractility. Circulation Research, 100 (3), 32-44. doi:10.1161/01.RES.0000259042.04576.6a
Peer Reviewed verified by ORBi

Oceandy, D., Stanley, P. J., Cartwright, E. J., & Neyses, L. (2007). The regulatory function of plasma-membrane Ca(2+)-ATPase (PMCA) in the heart. Biochemical Society transactions, 35 (Pt 5), 927-30. doi:10.1042/BST0350927
Peer reviewed

Holton, M., Yang, D., Wang, W., Mohamed, T. M. A., Neyses, L., & Armesilla, A. L. (2007). The interaction between endogenous calcineurin and the plasma membrane calcium-dependent ATPase is isoform specific in breast cancer cells. FEBS Letters, 581 (21), 4115-9. doi:10.1016/j.febslet.2007.07.054
Peer Reviewed verified by ORBi

Cartwright, E. J., Oceandy, D., & Neyses, L. (2007). Plasma membrane calcium ATPase and its relationship to nitric oxide signaling in the heart. Annals of the New York Academy of Sciences, 1099, 247-53. doi:10.1196/annals.1387.007
Peer reviewed

Oceandy, D., Yusoff, R., Baudoin, F. M., Neyses, L., & Ray, S. G. (2007). Promoter polymorphism of the matrix metalloproteinase 3 gene is associated with regurgitation and left ventricular remodelling in mitral valve prolapse patients. European journal of heart failure, 9 (10), 1010-7. doi:10.1016/j.ejheart.2007.07.005
Peer reviewed

Oceandy, D., Mamas, M. A., & Neyses, L. (2007). Targeting the sarcolemmal calcium pump: a potential novel strategy for the treatment of cardiovascular disease. Cardiovascular and Hematological Agents in Medicinal Chemistry, 5 (4), 300-4. doi:10.2174/187152507782109890
Peer Reviewed verified by ORBi

Arias-Loza, P. A., Hu, K., Schafer, A., Bauersachs, J., Quaschning, T., Galle, J., Jazbutyte, V., Neyses, L., Ertl, G., Fritzemeier, K.-H., Hegele-Hartung, C., & Pelzer, T. (2006). Medroxyprogesterone acetate but not drospirenone ablates the protective function of 17 beta-estradiol in aldosterone salt-treated rats. Hypertension, 48 (5), 994-1001. doi:10.1161/01.HYP.0000242482.57186.e8
Peer Reviewed verified by ORBi

Jazbutyte, V., Hu, K., Kruchten, P., Bey, E., Maier, S. K. G., Fritzemeier, K.-H., Prelle, K., Hegele-Hartung, C., Hartmann, R. W., Neyses, L., Ertl, G., & Pelzer, T. (2006). Aging reduces the efficacy of estrogen substitution to attenuate cardiac hypertrophy in female spontaneously hypertensive rats. Hypertension, 48 (4), 579-86. doi:10.1161/01.HYP.0000240053.48517.c7
Peer Reviewed verified by ORBi

Oceandy, D., Buch, M. H., Cartwright, E. J., & Neyses, L. (2006). The emergence of plasma membrane calcium pump as a novel therapeutic target for heart disease. Mini Reviews in Medicinal Chemistry, 6 (5), 583-8. doi:10.2174/138955706776876177
Peer Reviewed verified by ORBi

Gupta, S., & Neyses, L. (2006). Current thinking regarding the use of diuretics in heart failure. Heart Failure Monitor, 5 (2), 50-3.
Peer Reviewed verified by ORBi

Neyses, L. (2006). [Cardiology in Great Britain]. Deutsche medizinische Wochenschrift (1946), 131 (24), 1409-11. doi:10.1055/s-2006-946588
Peer reviewed

Hallhuber, M., Burkard, N., Wu, R., Buch, M. H., Engelhardt, S., Hein, L., Neyses, L., Schuh, K., & Ritter, O. (2006). Inhibition of nuclear import of calcineurin prevents myocardial hypertrophy. Circulation Research, 99 (6), 626-35. doi:10.1161/01.RES.0000243208.59795.d8
Peer Reviewed verified by ORBi

Williams, J. C., Armesilla, A. L., Mohamed, T. M. A., Hagarty, C. L., McIntyre, F. H., Schomburg, S., Zaki, A. O., Oceandy, D., Cartwright, E. J., Buch, M. H., Emerson, M., & Neyses, L. (2006). The sarcolemmal calcium pump, alpha-1 syntrophin, and neuronal nitric-oxide synthase are parts of a macromolecular protein complex. The Journal of biological chemistry, 281 (33), 23341-8. doi:10.1074/jbc.M513341200
Peer reviewed

Guo, C., Willem, M., Werner, A., Raivich, G., Emerson, M., Neyses, L., & Mayer, U. (2006). Absence of alpha 7 integrin in dystrophin-deficient mice causes a myopathy similar to Duchenne muscular dystrophy. Human molecular genetics, 15 (6), 989-98. doi:10.1093/hmg/ddl018
Peer reviewed

Arias-Loza, P. A., Jazbutyte, V., Fritzemeier, K. H., Hegele-Hartung, C., Neyses, L., Ertl, G., & Pelzer, T. (2006). Functional effects and molecular mechanisms of subtype-selective ERalpha and ERbeta agonists in the cardiovascular system. Ernst Schering Foundation symposium proceedings, (1), 87-106. doi:10.1007/2789_2006_018
Peer reviewed

Withers, S., Cartwright, E. J., & Neyses, L. (2006). Sperm phenotype of mice carrying a gene deletion for the plasma membrane calcium/calmodulin dependent ATPase 4. Molecular and Cellular Endocrinology, 250 (1-2), 93-7. doi:10.1016/j.mce.2005.12.028
Peer reviewed

Pelzer, T., Loza, P.-A. A., Hu, K., Bayer, B., Dienesch, C., Calvillo, L., Couse, J. F., Korach, K. S., Neyses, L., & Ertl, G. (2005). Increased mortality and aggravation of heart failure in estrogen receptor-beta knockout mice after myocardial infarction. Circulation, 111 (12), 1492-8. doi:10.1161/01.CIR.0000159262.18512.46
Peer Reviewed verified by ORBi

Burkard, N., Becher, J., Heindl, C., Neyses, L., Schuh, K., & Ritter, O. (2005). Targeted proteolysis sustains calcineurin activation. Circulation, 111 (8), 1045-53. doi:10.1161/01.CIR.0000156458.80515.F7
Peer Reviewed verified by ORBi

Bauer, S., Maier, S. K. G., Neyses, L., & Maass, A. H. (2005). Optimization of gene transfer into neonatal rat cardiomyocytes and unmasking of cytomegalovirus promoter silencing. DNA and cell biology, 24 (6), 381-7. doi:10.1089/dna.2005.24.381
Peer reviewed

Pelzer, T., Jazbutyte, V., Hu, K., Segerer, S., Nahrendorf, M., Nordbeck, P., Bonz, A. W., Muck, J., Fritzemeier, K.-H., Hegele-Hartung, C., Ertl, G., & Neyses, L. (2005). The estrogen receptor-alpha agonist 16alpha-LE2 inhibits cardiac hypertrophy and improves hemodynamic function in estrogen-deficient spontaneously hypertensive rats. Cardiovascular Research, 67 (4), 604-12. doi:10.1016/j.cardiores.2005.04.035
Peer Reviewed verified by ORBi

Buch, M. H., Pickard, A., Rodriguez, A., Gillies, S., Maass, A. H., Emerson, M., Cartwright, E. J., Williams, J. C., Oceandy, D., Redondo, J. M., Neyses, L., & Armesilla, A. L. (2005). The sarcolemmal calcium pump inhibits the calcineurin/nuclear factor of activated T-cell pathway via interaction with the calcineurin A catalytic subunit. The Journal of biological chemistry, 280 (33), 29479-87. doi:10.1074/jbc.M501326200
Peer reviewed

Pelzer, T., Jazbutyte, V., Arias-Loza, P. A., Segerer, S., Lichtenwald, M., Law, M. P., Schafers, M., Ertl, G., & Neyses, L. (2005). Pioglitazone reverses down-regulation of cardiac PPARgamma expression in Zucker diabetic fatty rats. Biochemical and biophysical research communications, 329 (2), 726-32. doi:10.1016/j.bbrc.2005.02.029
Peer reviewed

Gupta, S., & Neyses, L. (2005). Diuretic usage in heart failure: a continuing conundrum in 2005. European heart journal, 26 (7), 644-9. doi:10.1093/eurheartj/ehi176
Peer reviewed

Cartwright, E. J., Schuh, K., & Neyses, L. (2005). Calcium transport in cardiovascular health and disease--the sarcolemmal calcium pump enters the stage. Journal of Molecular and Cellular Cardiology, 39 (3), 403-6. doi:10.1016/j.yjmcc.2005.04.007
Peer reviewed

Armesilla, A. L., Williams, J. C., Buch, M. H., Pickard, A., Emerson, M., Cartwright, E. J., Oceandy, D., Vos, M. D., Gillies, S., Clark, G. J., & Neyses, L. (2004). Novel functional interaction between the plasma membrane Ca2+ pump 4b and the proapoptotic tumor suppressor Ras-associated factor 1 (RASSF1). The Journal of biological chemistry, 279 (30), 31318-28. doi:10.1074/jbc.M307557200
Peer reviewed

Schuh, K., Cartwright, E. J., Jankevics, E., Bundschu, K., Liebermann, J., Williams, J. C., Armesilla, A. L., Emerson, M., Oceandy, D., Knobeloch, K.-P., & Neyses, L. (2004). Plasma membrane Ca2+ ATPase 4 is required for sperm motility and male fertility. The Journal of biological chemistry, 279 (27), 28220-6. doi:10.1074/jbc.M312599200
Peer reviewed

Ritter, O., & Neyses, L. (2003). The molecular basis of myocardial hypertrophy and heart failure. Trends in Molecular Medicine, 9 (7), 313-21. doi:10.1016/S1471-4914(03)00114-X
Peer Reviewed verified by ORBi

Schuh, K., Uldrijan, S., Gambaryan, S., Roethlein, N., & Neyses, L. (2003). Interaction of the plasma membrane Ca2+ pump 4b/CI with the Ca2+/calmodulin-dependent membrane-associated kinase CASK. The Journal of biological chemistry, 278 (11), 9778-83. doi:10.1074/jbc.M212507200
Peer reviewed

Widder, J., Pelzer, T., von Poser-Klein, C., Hu, K., Jazbutyte, V., Fritzemeier, K.-H., Hegele-Hartung, C., Neyses, L., & Bauersachs, J. (2003). Improvement of endothelial dysfunction by selective estrogen receptor-alpha stimulation in ovariectomized SHR. Hypertension, 42 (5), 991-6. doi:10.1161/01.HYP.0000098661.37637.89
Peer Reviewed verified by ORBi

Schuh, K., Quaschning, T., Knauer, S., Hu, K., Kocak, S., Roethlein, N., & Neyses, L. (2003). Regulation of vascular tone in animals overexpressing the sarcolemmal calcium pump. The Journal of biological chemistry, 278 (42), 41246-52. doi:10.1074/jbc.M307606200
Peer reviewed

Ritter, O., Schuh, K., Brede, M., Rothlein, N., Burkard, N., Hein, L., & Neyses, L. (2003). AT2 receptor activation regulates myocardial eNOS expression via the calcineurin-NF-AT pathway. FASEB Journal, 17 (2), 283-5. doi:10.1096/fj.02-0321fje
Peer Reviewed verified by ORBi

Maass, A., Langer, S. J., Oberdorf-Maass, S., Bauer, S., Neyses, L., & Leinwand, L. A. (2003). Rational promoter selection for gene transfer into cardiac cells. Journal of Molecular and Cellular Cardiology, 35 (7), 823-31. doi:10.1016/S0022-2828(03)00140-8
Peer reviewed

Ritter, O., Hack, S., Schuh, K., Rothlein, N., Perrot, A., Osterziel, K. J., Schulte, H. D., & Neyses, L. (2002). Calcineurin in human heart hypertrophy. Circulation, 105 (19), 2265-9. doi:10.1161/01.CIR.0000016044.19527.96
Peer Reviewed verified by ORBi

Pelzer, T., de Jager, T., Muck, J., Stimpel, M., & Neyses, L. (2002). Oestrogen action on the myocardium in vivo: specific and permissive for angiotensin-converting enzyme inhibition. Journal of Hypertension, 20 (5), 1001-6. doi:10.1097/00004872-200205000-00036
Peer Reviewed verified by ORBi

Bonz, A. W., Lengenfelder, B., Strotmann, J., Held, S., Turschner, O., Harre, K., Wacker, C., Waller, C., Kochsiek, N., Meesmann, M., Neyses, L., Schanzenbacher, P., Ertl, G., & Voelker, W. (2002). Effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial). Journal of the American College of Cardiology, 40 (4), 662-8. doi:10.1016/S0735-1097(02)02014-4
Peer reviewed

Ritter, O., Bottez, N., Burkard, N., Schulte, H. D., & Neyses, L. (2002). A molecular mechanism improving the contractile state in human myocardial hypertrophy. Experimental and Clinical Cardiology, 7 (2-3), 151-7.
Peer reviewed

Piuhola, J., Hammes, A., Schuh, K., Neyses, L., Vuolteenaho, O., & Ruskoaho, H. (2001). Overexpression of sarcolemmal calcium pump attenuates induction of cardiac gene expression in response to ET-1. American journal of physiology. Regulatory, integrative and comparative physiology, 281 (3), 699-705. doi:10.1152/ajpregu.2001.281.3.r699
Peer reviewed

Schuh, K., Uldrijan, S., Telkamp, M., Rothlein, N., & Neyses, L. (2001). The plasmamembrane calmodulin-dependent calcium pump: a major regulator of nitric oxide synthase I. The Journal of cell biology, 155 (2), 201-5. doi:10.1083/jcb.200104131
Peer reviewed

Pelzer, T., Neumann, M., de Jager, T., Jazbutyte, V., & Neyses, L. (2001). Estrogen effects in the myocardium: inhibition of NF-kappaB DNA binding by estrogen receptor-alpha and -beta. Biochemical and biophysical research communications, 286 (5), 1153-7. doi:10.1006/bbrc.2001.5519
Peer reviewed

de Jager, T., Pelzer, T., Muller-Botz, S., Imam, A., Muck, J., & Neyses, L. (2001). Mechanisms of estrogen receptor action in the myocardium. Rapid gene activation via the ERK1/2 pathway and serum response elements. The Journal of biological chemistry, 276 (30), 27873-80. doi:10.1074/jbc.M010984200
Peer reviewed

Pelzer, T., Neumann, M., deJager, T., Stimpel, M., Serfling, E., Neyses, L., & Michael, S. (2000). 17beta-estradiol prevents programmed cell death in cardiac myocytes. Biochemical and biophysical research communications, 268 (1), 192-200. doi:10.1006/bbrc.2000.2073
Peer reviewed

Benkwitz, C., Oberdorf-Maass, S., & Neyses, L. (1999). Combined SSCP and heteroduplex analysis of the human plasma membrane Ca(2+)-ATPase isoform 1 in patients with essential hypertension. Biochemical and biophysical research communications, 261 (2), 515-20. doi:10.1006/bbrc.1999.1064
Peer reviewed

Shamim, A., Pelzer, T., Grohe, C., & Neyses, L. (1999). Induction of Egr-1 mRNA and protein by endothelin 1, angiotensin II and norepinephrine in neonatal cardiac myocytes. Molecular and Cellular Biochemistry, 195 (1-2), 11-7. doi:10.1023/A:1006887307568
Peer reviewed

Grohe, C., Kahlert, S., Lobbert, K., Neyses, L., van Eickels, M., Stimpel, M., & Vetter, H. (1998). Angiotensin converting enzyme inhibition modulates cardiac fibroblast growth. Journal of Hypertension, 16 (3), 377-84. doi:10.1097/00004872-199816030-00015
Peer Reviewed verified by ORBi

Hammes, A., Oberdorf-Maass, S., Rother, T., Nething, K., Gollnick, F., Linz, K. W., Meyer, R., Hu, K., Han, H., Gaudron, P., Ertl, G., Hoffmann, S., Ganten, U., Vetter, R., Schuh, K., Benkwitz, C., Zimmer, H. G., & Neyses, L. (1998). Overexpression of the sarcolemmal calcium pump in the myocardium of transgenic rats. Circulation Research, 83 (9), 877-88. doi:10.1161/01.RES.83.9.877
Peer reviewed

Beer, M., Tschammler, A., Wittenberg, G., Neyses, L., & Hahn, D. (1998). [Compression therapy of a ruptured spurious aneurysm]. RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren, 168 (3), 291-3. doi:10.1055/s-2007-1015128
Peer reviewed

Pelzer, T., Shamim, A., Wolfges, S., Schumann, M., & Neyses, L. (1997). Modulation of cardiac hypertrophy by estrogens. In A. Zanchetti, R. B. Devereux, L. Hansson, ... S. Gorini (Eds.), Hypertension and the Heart (pp. 83-9). New York, United States: Plenum Press. doi:10.1007/978-1-4615-5385-4_9
Peer reviewed

Neyses, L., & Pelzer, T. (1997). Sex specific mechanisms of cardiovascular disease. In M. Stimpel & A. Zanchetti (Eds.), Hypertension after menopause (pp. 93-100). Berlin, Unknown/unspecified: Walter de Gruyter.
Peer reviewed

Neyses, L., Pelzer, T., Maas, A., & Kochsiek, K. (1997). Was ist bei Vorhofflimmern zu beachten? Der Bayerische Internist, (17), 24-29.
Peer reviewed

Grohe, C., Kahlert, S., Lobbert, K., van Eickels, M., Stimpel, M., Vetter, H., & Neyses, L. (1997). Effects of moexiprilat on oestrogen-stimulated cardiac fibroblast growth. British Journal of Pharmacology, 121 (7), 1350-4. doi:10.1038/sj.bjp.0701263
Peer Reviewed verified by ORBi

Grohe, C., Kahlert, S., Lobbert, K., Stimpel, M., Karas, R. H., Vetter, H., & Neyses, L. (1997). Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Letters, 416 (1), 107-12. doi:10.1016/S0014-5793(97)01179-4
Peer Reviewed verified by ORBi

Kahlert, S., Grohe, C., Karas, R. H., Lobbert, K., Neyses, L., & Vetter, H. (1997). Effects of estrogen on skeletal myoblast growth. Biochemical and biophysical research communications, 232 (2), 373-8. doi:10.1006/bbrc.1997.6223
Peer reviewed

Benkwitz, C., Kubisch, C., Kraft, K., & Neyses, L. (1997). Investigation of the Met-267 Arg exchange in isoform 1 of the human plasma membrane calcium pump in patients with essential hypertension by the amplification-created restriction site technique. Journal of Molecular Medicine, 75 (1), 62-6. doi:10.1007/s001090050088
Peer reviewed

Dominiak, P., Erdmann, E., Kreuzer, H., Buchwald, A. B., Motz, W., Neyses, L., & Unger, T. (1996). [Beta blockers in chronic heart failure. Clinical position on the topic]. Der Internist, 37 (12), 1274-8; discussion 1279.
Peer reviewed

Neyses, L., Blaufuss, B., Kubisch, C., Wollnik, B., Maass, A., Oberdorf, S., Grohe, C., & Vetter, H. (1996). Use of antisense oligonucleotides for selective inhibition of gene expression in cardiomyocytes. In J. Grote & C. Stick (Eds.), Tissue response to hypoxia and ischemia (pp. 53-62). Stuttgart, Unknown/unspecified: Fischer Verlag.
Peer reviewed

Neyses, L., Grohe, C., & Vetter, H. (1996). Molecular Biology of oncogenes and cardiovascular hypertrophy. In K. Lindpaintner & D. Ganten (Eds.), Molecular Reviews in Cardiovascular Medicine (pp. 89-105). London, Unknown/unspecified: Chapman and Hall.
Peer reviewed

Neyses, L. (1996). Molekulare Mekchanismen der Myokardhypertrophie. In M. Ludwig & U. Winter (Eds.), Arterosklerotische Gefaessserkrankungen (pp. 25-31). Bonn, Unknown/unspecified: Kargerer Kommunikation.
Peer reviewed

Hammes, A., Oberdorf-Maass, S., Jenatschke, S., Pelzer, T., Maass, A., Gollnick, F., Meyer, R., Afflerbach, J., & Neyses, L. (1996). Expression of the plasma membrane Ca2+-ATPase in myogenic cells. The Journal of biological chemistry, 271 (48), 30816-22. doi:10.1074/jbc.271.48.30816
Peer reviewed

Pelzer, T., Shamim, A., & Neyses, L. (1996). Estrogen effects in the heart. Molecular and Cellular Biochemistry, 160-161, 307-13. doi:10.1007/BF00240064
Peer reviewed

Maass, A., Grohe, C., Kubisch, C., Wollnik, B., Vetter, H., & Neyses, L. (1995). Hormonal induction of an immediate-early gene response in myogenic cell lines--a paradigm for heart growth. European heart journal, 16 Suppl C, 12-4. doi:10.1093/eurheartj/16.suppl_C.12
Peer reviewed

Neyses, L., & Pelzer, T. (1995). The biological cascade leading to cardiac hypertrophy. European heart journal, 16 Suppl N, 8-11. doi:10.1093/eurheartj/16.suppl_N.8
Peer reviewed

Neyses, L., & Pelzer, T. (1995). [Molecular adaptation of the heart to hypertension]. Zeitschrift fur Kardiologie, 84 Suppl 4, 71-6.
Peer reviewed

Neyses, L. (1995). Calcium transport systems in pressure overload cardiomyopathy. In M. Timio, V. Wizemann, ... S. Venanzi (Eds.), Cardionephrology (pp. 327-330). Editorial Bios.
Peer reviewed

Maass, A., Grohe, C., Oberdorf, S., Sukhatme, V. P., Vetter, H., & Neyses, L. (1994). Mitogenic signals control translation of the early growth response gene-1 in myogenic cells. Biochemical and biophysical research communications, 202 (3), 1337-46. doi:10.1006/bbrc.1994.2077
Peer reviewed

Grohe, C., Nouskas, J., Vetter, H., & Neyses, L. (1994). Effects of nisoldipine on endothelin-1- and angiotensin II-induced immediate/early gene expression and protein synthesis in adult rat ventricular cardiomyocytes. Journal of cardiovascular pharmacology, 24 (1), 13-6. doi:10.1097/00005344-199407000-00003
Peer reviewed

Hammes, A., Oberdorf, S., Strehler, E. E., Stauffer, T., Carafoli, E., Vetter, H., & Neyses, L. (1994). Differentiation-specific isoform mRNA expression of the calmodulin-dependent plasma membrane Ca(2+)-ATPase. FASEB Journal, 8 (6), 428-35. doi:10.1096/fasebj.8.6.8168693
Peer reviewed

Neyses, L., Nouskas, J., Luyken, J., Fronhoffs, S., Oberdorf, S., Pfeifer, U., Williams, R. S., Sukhatme, V. P., & Vetter, H. (1993). Induction of immediate-early genes by angiotensin II and endothelin-1 in adult rat cardiomyocytes. Journal of Hypertension, 11 (9), 927-34. doi:10.1097/00004872-199309000-00006
Peer Reviewed verified by ORBi

Wollnik, B., Kubisch, C., Maass, A., Vetter, H., & Neyses, L. (1993). Hyperosmotic stress induces immediate-early gene expression in ventricular adult cardiomyocytes. Biochemical and biophysical research communications, 194 (2), 642-6. doi:10.1006/bbrc.1993.1869
Peer reviewed

Bastide, B., Neyses, L., Ganten, D., Paul, M., Willecke, K., & Traub, O. (1993). Gap junction protein connexin40 is preferentially expressed in vascular endothelium and conductive bundles of rat myocardium and is increased under hypertensive conditions. Circulation Research, 73 (6), 1138-49. doi:10.1161/01.RES.73.6.1138
Peer reviewed

Kubisch, C., Wollnik, B., Maass, A., Meyer, R., Vetter, H., & Neyses, L. (1993). Immediate-early gene induction by repetitive mechanical but not electrical activity in adult rat cardiomyocytes. FEBS Letters, 335 (1), 37-40. doi:10.1016/0014-5793(93)80434-V
Peer Reviewed verified by ORBi

Neyses, L., & Vetter, H. (1992). Molecular biology of oncogenes and cardiovascular hypertrophy. Journal of Hypertension, 10 (12), 1447-52. doi:10.1007/978-94-009-0083-7_11
Peer Reviewed verified by ORBi

Neyses, L., Maass, A., Wollnik, B., Kubisch, C., Oberdorf, S., & Vetter, H. (1992). Die Bedeutung des "early growth response gene-1" bei der Induktion der Hypertensiven Myokardhypertrophie. In Regensburger Universitaetskolloquium: Fortschritte in der medizinischen Forschung - Hypertonie - molekulare Mechanismen/funktionelle Adaptation (pp. 56-66). Schattauer Verlag.
Peer reviewed

Neyses, L. (1992). [Potassium restriction and essential hypertension]. Deutsche medizinische Wochenschrift (1946), 117 (35), 1341.
Peer reviewed

Volkenandt, M., Koch, O., Fanin, R., Banerjee, D., Seger, A., Vogel, J., Bierhoff, E., Heidl, G., Neyses, L., & Bertino, J. R. (1992). Sequence analysis of polymerase chain reaction amplified t(14;18) chromosomal breakpoints in formalin fixed, paraffin wax embedded follicular lymphoma. Journal of clinical pathology, 45 (3), 210-2. doi:10.1136/jcp.45.3.210
Peer reviewed

Sachinidis, A., Weisser, P., Ko, Y., Schulte, K., Meyer zu Brickwedde, K., Neyses, L., & Vetter, H. (1992). Angiotensin II induces formation of the early growth response gene-1 protein in rat vascular smooth muscle cells. FEBS Letters, 313 (2), 109-12. doi:10.1016/0014-5793(92)81423-J
Peer Reviewed verified by ORBi

Neyses, L., Nouskas, J., & Vetter, H. (1991). Inhibition of endothelin-1 induced myocardial protein synthesis by an antisense oligonucleotide against the early growth response gene-1. Biochemical and biophysical research communications, 181 (1), 22-7. doi:10.1016/S0006-291X(05)81376-2
Peer reviewed

Neyses, L., Molls, M., Pelzer, T., Oberdorf, S., & Vetter, H. (1991). Isolierte Kardiomyozyten - ein Modell zur Aufklaerung der Pathophysiologie der hypertensiven Herzkrankheit - physiologische und erste molekularbiologische Ergebnisse. In D. Ganten (Ed.), Herz-Kreislaufregulation, Organprotektion und Organschaden (pp. 23-31). Springer.
Peer reviewed

Neyses, L. (1991). Kalium-Restriktion und essentielle Hypertonie. Deutsche Medizinische Wochenschrift (1946), (116), 2417-2248.
Peer reviewed

Neyses, L., & Vetter, H. (1990). [Hypertensive heart disease. Pathophysiological foundation, diagnosis and therapy]. Deutsche medizinische Wochenschrift (1946), 115 (39), 1480-6. doi:10.1055/s-2008-1065182
Peer reviewed

Neyses, L., & Vetter, H. (1990). [Disturbed endothelium-dependent blood vessel relaxation in essential hypertension]. Deutsche medizinische Wochenschrift (1946), 115 (51-52), 1981.
Peer reviewed

Neyses, L., & Vetter, H. (1990). Hypertensive Herzkrankheit - pathophysiologische Grundlaten, Diagnostik und Therapie. Deutsche Medizinische Wochenschrift (1946), (39), 1480-1486.
Peer reviewed

Neyses, L., & Vetter, H. (1990). Isolated myocardial cells: a new tool for the investigation of hypertensive heart disease. Journal of Hypertension. Supplement), 8 (4), 99-102.
Peer Reviewed verified by ORBi

Neyses, L., Nitsch, J., Tuttenberg, H. P., Korus, H. C., & Luderitz, B. (1989). [Increased atrial natriuretic peptide in essential hypertension--relation to right atrial pressure behavior]. Klinische Wochenschrift, 67 (15), 756-61. doi:10.1007/BF01745345
Peer Reviewed verified by ORBi

Neyses, L., & Vetter, H. (1989). Action of atrial natriuretic peptide and angiotensin II on the myocardium: studies in isolated rat ventricular cardiomyocytes. Biochemical and biophysical research communications, 163 (3), 1435-43. doi:10.1016/0006-291X(89)91139-X
Peer reviewed

Neyses, L., & Vetter, H. (1989). Impaired relaxation of the hypertrophied myocardium is potentiated by angiotensin II. Journal of Hypertension. Supplement), 7 (6), 104-5. doi:10.1097/00004872-198900076-00048
Peer Reviewed verified by ORBi

Nitsch, J., Kohler, U., Neyses, L., & Luderitz, B. (1988). [Concentrations of amiodarone and flecainide in plasma and saliva--indications for the active transport of flecainide]. Zeitschrift fur Kardiologie, 77 (2), 99-102.
Peer reviewed

Neyses, L., Biegel, H., Heinrichs, S., Nitsch, J., & Luderitz, B. (1988). [Diagnostic and prognostic value of plasma ANP determination after myocardial infarction]. Zeitschrift fur Kardiologie, 77 Suppl 2, 51-4.
Peer reviewed

Neyses, L., Stimpel, M., Locher, R., & Luederitz, B. (1988). Oxygenated sterols and intracellular calcium dynamics - comparison with cholesterol and clinical application. In J. Beck & A. Crastes de Paulet (Eds.), Biological activities of oxygenated sterols (pp. 101-106). Paris, Unknown/unspecified: INSERM Ed.
Peer reviewed

Neyses, L., Biegel, T., Heinrichs, S., Nitsch, J., & Luederitz, B. (1988). Diagnostische und prognostische Bedeutung der Plasma-ANP-Messung nach Myokardinfarkt. In Plasmabestimmung des atrialen natriuretischen Peptids (pp. 51-54). Darmstadt, Unknown/unspecified: Steinkopff Verlag.
Peer reviewed

Neyses, L., Nitsch, J., Biegel, T., Heinrichs, S., Nissen, H. D., & Luderitz, B. (1988). [Elevated levels of atrial natriuretic peptide and plasma catecholamines in arterial hypertension--indications for an interaction]. Zeitschrift fur Kardiologie, 77 (7), 407-12.
Peer reviewed

Nitsch, J., Neyses, L., Kohler, U., & Luderitz, B. (1987). [Elevated plasma flecainide concentrations in heart failure]. Deutsche medizinische Wochenschrift (1946), 112 (44), 1698-700. doi:10.1055/s-2008-1068315
Peer reviewed

Neyses, L., Nitsch, J., Manz, M., & Luderitz, B. (1987). [Resuscitation of a 36-year-old patient with a short PQ time and a history of Hodgkin's disease]. Der Internist, 28 (3), 196-9.
Peer reviewed

Nitsch, J., Kohler, U., Neyses, L., & Luderitz, B. (1987). Inhibition of flecainide absorption by activated charcoal. The American journal of cardiology, 60 (8), 753. doi:10.1016/0002-9149(87)90405-X
Peer reviewed

Neyses, L., Nitsch, J., Heinrichs, S., Biegel, T., & Luederitz, B. (1987). Einfluss von oraler Volumenbelastung, Herzfrequenz und Reserpin auf die Sekretion von atrialem natriuretischen Peptid beim Menschen. In V. Kreye & W. Bussmann (Eds.), Atriales natriurestisches Peptid und das kardiovaskulaere System (pp. 131-138). Darmstadt, Unknown/unspecified: Steinkopff-Verlag.
Peer reviewed

Neyses, L., Groth, H., Vetter, H., & Vetter, W. (1985). Trilostane - a new and effective drug for primary aldosteronism. In The adrenal gland and hypertension (pp. 443-448). United States: Raven Press.
Peer reviewed

Neyses, L., Reinlib, L., & Carafoli, E. (1985). Phosphorylation of the Ca2+-pumping ATPase of heart sarcolemma and erythrocyte plasma membrane by the cAMP-dependent protein kinase. The Journal of biological chemistry, 260 (18), 10283-7.
Peer reviewed

Neyses, L., Locher, R., Stimpel, M., Streuli, R., & Vetter, W. (1985). Stereospecific modulation of the calcium channel in human erythrocytes by cholesterol and its oxidized derivatives. The Biochemical journal, 227 (1), 105-12. doi:10.1042/bj2270105
Peer reviewed

Stimpel, M., Neyses, L., Locher, R., Knorr, M., & Vetter, W. (1985). High density lipoproteins--modulators of the calcium channel? Journal of Hypertension. Supplement), 3 (3), 49-51.
Peer Reviewed verified by ORBi

Neyses, L., Dorst, K., Michaelis, J., Berres, M., Philipp, T., Distler, A., Losse, H., Vetter, H., Epstein, F. H., & Vetter, W. (1985). Compliance with salt restriction as a limiting factor in the primary prevention of hypertension. Journal of Hypertension. Supplement), 3 (1), 87-90.
Peer Reviewed verified by ORBi

Neyses, L., Greminger, P., Bartsch, A., Luscher, T., Keller, U., Bachmann, L., Siegenthaler, W., & Vetter, W. (1985). A simple and effective method to teach patients about high blood pressure and obesity. Journal of Hypertension. Supplement), 3 (1), 27-30.
Peer Reviewed verified by ORBi

Stimpel, M., & Neyses, L. (1985). The mechanism of action of calcium antagonists [DER WIRKUNGSMECHANISMUS DER KALZIUMANTAGONISTEN]. Schweizerische Rundschau für Medizin Praxis, 74 (19), 483-490.
Peer Reviewed verified by ORBi

Stimpel, M., Vetter, H., Kuffer, B., Neyses, L., Greminger, P., Groth, H., & Vetter, W. (1985). [Divisible tablets--source of error in therapeutic drug dosages]. Schweizerische Rundschau für Medizin Praxis, 74 (5), 84-6.
Peer Reviewed verified by ORBi

Stimpel, M., & Neyses, L. (1985). [Mechanism of action of calcium antagonists]. Schweizerische Rundschau für Medizin Praxis, 74 (19), 483-90.
Peer Reviewed verified by ORBi

Locher, R., Neyses, L., Stimpel, M., Kuffer, B., & Vetter, W. (1984). The cholesterol content of the human erythrocyte influences calcium influx through the channel. Biochemical and biophysical research communications, 124 (3), 822-8. doi:10.1016/0006-291X(84)91031-3
Peer reviewed

Neyses, L., Locher, R., Wehling, M., Pech, H., Tenschert, W., & Vetter, W. (1984). Angiotensin II binding to human mononuclear cells: receptor or free fluid endocytosis? Clinical Science, 66 (5), 605-12. doi:10.1042/cs0660605
Peer reviewed

Stimpel, M., Neyses, L., Locher, R., Groth, H., & Vetter, W. (1984). Human red blood cells--an ideal model system for the action of calcium agonists and antagonists. Journal of Hypertension. Supplement), 2 (3), 577-80.
Peer Reviewed verified by ORBi

Neyses, L., Stimpel, M., Locher, R., Streuli, R., Kuffer, B., & Vetter, W. (1984). Cholesterol and its oxidized derivatives modulate the calcium channel in human red blood cells. Journal of Hypertension. Supplement), 2 (3), 489-92.
Peer Reviewed verified by ORBi

Groth, H., Foerster, E. C., Neyses, L., Kulhmann, U., Vetter, H., & Vetter, W. (1984). [Nifedipine in hypertensive emergencies and severe hypertension]. Schweizerische Rundschau für Medizin Praxis, 73 (2), 45-9.
Peer Reviewed verified by ORBi

Bartsch, A., Neyses, L., Greminger, P., Luscher, T., Keller, U., Bachmann, L., Siegenthaler, W., & Vetter, W. (1983). A slide program on hypertension and obesity: a simple method of patient information. Schweizerische Medizinische Wochenschrift, 113 (50), 1929-33.
Peer Reviewed verified by ORBi

Wehling, M., Vetter, W., Neyses, L., Groth, H., Boerlin, H. J., Locher, R., Siegenthaler, W., & Kuhlmann, U. (1983). Altered calcium and sodium metabolism in red blood cells of hypertensive man: assessment by ion-selective electrodes. Journal of Hypertension, 1 (2), 171-6. doi:10.1097/00004872-198308000-00010
Peer Reviewed verified by ORBi

Neyses, L., Groth, H., & Vetter, W. (1983). Acceptability in food of NaCl/KCl mixture. Lancet, 2 (8364), 1427-8. doi:10.1016/S0140-6736(83)90964-9
Peer reviewed

Neyses, L. (1983). Beta-blockade in den achtziger Jahren. Swiss Medical Weekly, (4), 79-84.
Peer Reviewed verified by ORBi

Greminger, P., Kuhlmann, U., Vetter, W., Gruntzig, A., Schneider, E., Pouliadis, G., Wehling, M., Neyses, L., & Siegenthaler, W. (1982). [Long-term progress following percutaneous transluminal dilatation of renal artery stenosis]. VASA. Zeitschrift fur Gefasskrankheiten, 11 (4), 362-6.
Peer reviewed

Mussel, H. H., Ehlen, T., Schmitt, M., Kazatchkine, M. D., Neyses, L., & Dierich, M. P. (1982). Isolation and characterization of the C3b-binding entity of C3b-receptor from human erythrocytes. Immunology letters, 4 (1), 1-6. doi:10.1016/0165-2478(82)90069-4
Peer reviewed

Contact ORBilu